Analysis of clinical, iconographical and pathological characteristics, prognosis and treatment methods for 35 cases of Langerhans cell histiocytosis

• Published in: Zhongguo shi yan xue ye xue za zhi Vol. 22; no. 4; p. 1109
• Main Authors: Yang, Hua, Han, Xiao-Ping, Li, Bao-Jing, Sun, Lu, Zhu, Hai-Yan, Li, Fei, Wang, Quan-Shun, Huang, Wen-Rong, Bo, Jian, Zhao, Yu, Li, Hong-Hua, Wang, Shu-Hong, Yu, Li, Jing, Yu
• Format: Journal Article
• Language: Chinese
• Published: China 01.08.2014
• Subjects: Adolescent; Adult; Child; Child, Preschool; Female; Histiocytosis, Langerhans-Cell - diagnosis; Histiocytosis, Langerhans-Cell - drug therapy; Histiocytosis, Langerhans-Cell - pathology; Humans; Infant; Male; Middle Aged; Prognosis; Retrospective Studies; Young Adult
• ISSN: 1009-2137
• DOI: 10.7534/j.issn.1009-2137.2014.04.042

Purpose of this study was to analyse the characteristics of clinical, iconographical, pathological and treatment methods of Langerhans cell histiocytosis (LCH), so as to improve the diagnosis and treatment level of this disease. The clinical data of 35 LCH patients were studied retrospectively. These patients were divided into 2 groups according to age <14 years old and ≥ 14 years old. The clinical symptoms were analysed and the signs, imageology and pathology manifestation and treatment results were evaluated. The results showed that LCH clinical manifestations were diverse and complex. Surgical treatment for patients with single system involvement of LCH was better than that of multi-system involvement of LCH (MS-LCH). For the latter, combined chemotherapy effects was better. After 3-year follow-up, 1-year OS was 94% ± 4%, 2-years OS was 91% ± 5%, 3-year OS was 86% ± 7%. 3 years OS of group <14 years old and ≥ 14 years old was 94% ± 6% and 81% ± 10% respectively. The OS of former was better than that of the